Letter to the Editor

Eur Rev Med Pharmacol Sci 2019; 23 (5): 1841-1844
DOI: 10.26355/eurrev_201903_17217

Evaluation of genotyping methods and costs for MTHFR, CBS and MTRR polymorphisms in patients with vitiligo

S. Di Martino, T. Muto, V. de Lucia
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (4): 1386-1387
DOI: 10.26355/eurrev_201902_17094

Dipyridamole stress echocardiography for the diagnosis of cardiac allograft vasculopathy in heart transplant recipients

I. Álvarez Pichel, O.C. Fernández Cimadevilla, J.M. De la Hera Galarza, M. Martín Fernández
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (4): 1384-1385
DOI: 10.26355/eurrev_201902_17093

Comment on: Expressions of MiR-132 in patients with chronic hepatitis B, posthepatitic cirrhosis and hepatitis B virus-related hepatocellular carcinoma

B. Santella, D. Pignataro, M.A. Lavano, M. Rinaldi, F. Galdiero
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (4): 1382-1383
DOI: 10.26355/eurrev_201902_17092

Comment on “Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation”

F. Fiorica, G. Anania
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (4): 1379-1381
DOI: 10.26355/eurrev_201902_17091

Uterine rupture during induced labor after myomectomy and risk of lawsuits

S. Zaami, G. Montanari Vergallo, A. Malvasi, E. Marinelli
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (3): 908-910
DOI: 10.26355/eurrev_201902_16973

The issue of psychotropic drug monitoring in sexual assault victims

A. Minutillo, S. Pichini, C. Mortali, R. Tittarelli, A. Tini, F.P. Busardò
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (3): 906-907
DOI: 10.26355/eurrev_201902_16971

Comment on “Research on values of GDF-15 level in the diagnosis of primary liver cancer and evaluation of chemotherapeutic effect”

R. Fisichella, L. Izzo, S. Berretta
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (3): 903-905
DOI: 10.26355/eurrev_201902_16970

The radiation oncologist point of view on “Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation”

M.A. Signor, G. Parisi, G. Chiaulon, M. Trovo
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (23): 8061-8062
DOI: 10.26355/eurrev_201812_16494

Is microbiome a target for the management of allergy associated diseases in children?

D.G. Ribaldone, M. Vernero, R. Pellicano
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (20): 6573-6574
DOI: 10.26355/eurrev_201810_16130

Comment on “Neuronal nitric oxide synthase inhibition reduces brain damage by promoting collateral recruitment” in a cerebral hypoxia-ischemia mice model

C. Charriaut-Marlangue, P. Bonnin
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (19): 6173-6174
DOI: 10.26355/eurrev_201810_16021

Comment on: Short-term effect of metronomic chemotherapy of low dose Tegafur on patients with primary hepatic carcinoma after radiofrequency ablation

R. Fisichella, S. Benfatto, S. Berretta
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (19): 6171-6172
DOI: 10.26355/eurrev_201810_16020

Comment on: Comorbidities in coexisting chronic obstructive pulmonary disease and obstructive sleep apnea – overlap syndrome

A. Voulgaris, E. Nena, P. Steiropoulos
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (18): 5773-5774
DOI: 10.26355/eurrev_201809_15902

Microbiome and bariatric surgery: new options to precision surgery

P. Gualtieri, L. Romano, G. Capria, G. Merra
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (18): 5771-5772
DOI: 10.26355/eurrev_201809_15901

Neurodegenerative disorders, gut human microbiome and diet: future research for prevention and supportive therapies

L. Romano, P. Gualtieri, F. Nicoletti, G. Merra
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (18): 5769-5770
DOI: 10.26355/eurrev_201809_15900

MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3. It is a cost-effective genetic test

S. Di Martino, C. Di Iorio, G. Marotta
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (18): 5767-5768
DOI: 10.26355/eurrev_201809_15898

Comment on: Omega-3 polyunsaturated fatty acid inhibits the malignant progression of hepatocarcinoma by inhibiting the Wnt/β-catenin pathway

M.C. Fascione, A. Amelia, P.C. Pafundi
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (17): 5413-5415
DOI: 10.26355/eurrev_201809_15799

The Territorial Ethics Committee after approval of Italian Law No. 220/2017

A.G. Spagnolo, E. Midolo
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (17): 5411-5412
DOI: 10.26355/eurrev_201809_15798

Comment on: Correlation between HSD17B4 expression in rat liver cancer tissues and inflammation or proliferation

S. Milione, E. Allegorico, C. Altruda
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (16): 5053-5055
DOI: 10.26355/eurrev_201808_15696

Long non-coding RNAs: possible parallel paths by E-cadherin expression in colon cancer development as well as in Pseudomonas aeruginosa infection

A. Scano, G. Orrù, G. Serafi, A. Occhinegro, D. Ratto, C. Girometta, P. Rossi
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (16): 5051-5052
DOI: 10.26355/eurrev_201808_15695

MiR-431 inhibits colorectal cancer cell invasion via repressing CUL4B

R. Fisichella, A. Cappellani, S. Berretta
Free PDF Download